Esophagitis [clinicaltrials_resource:43a6013a987f1405a4b7c73ec4918ffa]
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer [clinicaltrials:NCT00081315]clinicaltrials:NCT00123630Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis [clinicaltrials:NCT00123656]clinicaltrials:NCT00133770Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis [clinicaltrials:NCT00175045]Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis [clinicaltrials:NCT00195208]The Effect of Nexium on Transmucosal Esophageal Leak [clinicaltrials:NCT00216788]Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia [clinicaltrials:NCT00256529]Study to Identify Non-Invasive Markers of Gastrointestinal Allergy [clinicaltrials:NCT00272818]clinicaltrials:NCT00284908Intravenous Mepolizumab In Children With Eosinophilic Esophagitis [clinicaltrials:NCT00358449]clinicaltrials:NCT00471094Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis [clinicaltrials:NCT00523354]Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule [clinicaltrials:NCT00579410]Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain [clinicaltrials:NCT00677378]Domperidone for Relief of Gastrointestinal Disorders [clinicaltrials:NCT00761254]Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) [clinicaltrials:NCT00842387]Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) [clinicaltrials:NCT00872755]clinicaltrials:NCT01262560clinicaltrials:NCT01322633Eosinophilic Esophagitis Databank [clinicaltrials:NCT01323803]Esophageal Monitoring Device for Assessing Mucosal Impedance [clinicaltrials:NCT01556919]clinicaltrials:NCT01733810CYP2C19 Genotype Predictor of Gastric Acid Suppression [clinicaltrials:NCT01824199]
condition [clinicaltrials_vocabulary:condition]
Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [clinicaltrials:NCT00002041]A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis [clinicaltrials:NCT00005921]Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer [clinicaltrials:NCT00081315]clinicaltrials:NCT00123630Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis [clinicaltrials:NCT00123656]clinicaltrials:NCT0013377024 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis [clinicaltrials:NCT00154570]Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus [clinicaltrials:NCT00155805]Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis [clinicaltrials:NCT00175045]Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis [clinicaltrials:NCT00195208]NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis [clinicaltrials:NCT00206180]A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. [clinicaltrials:NCT00206245]A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. [clinicaltrials:NCT00206284]The Effect of Nexium on Transmucosal Esophageal Leak [clinicaltrials:NCT00216788]Esomeprazole for Treatment of GERD in Pediatric Patients [clinicaltrials:NCT00228527]clinicaltrials:NCT00229424clinicaltrials:NCT00251693clinicaltrials:NCT00251719clinicaltrials:NCT00255151clinicaltrials:NCT00255164Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia [clinicaltrials:NCT00256529]Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome [clinicaltrials:NCT00266565]A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders [clinicaltrials:NCT00266578]Data Bank for Eosinophilic Disorders [clinicaltrials:NCT00267475]Budesonide for Eosinophilic Esophagitis [clinicaltrials:NCT00271349]Study to Identify Non-Invasive Markers of Gastrointestinal Allergy [clinicaltrials:NCT00272818]An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients [clinicaltrials:NCT00274703]clinicaltrials:NCT00275561Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis [clinicaltrials:NCT00282555]clinicaltrials:NCT00284908clinicaltrials:NCT00321737Intravenous Mepolizumab In Children With Eosinophilic Esophagitis [clinicaltrials:NCT00358449]clinicaltrials:NCT00426283clinicaltrials:NCT00471094Trial of Montelukast in Eosinophilic Esophagitis [clinicaltrials:NCT00511316]Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis [clinicaltrials:NCT00523354]Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years [clinicaltrials:NCT00538434]Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule [clinicaltrials:NCT00579410]Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis [clinicaltrials:NCT00586963]clinicaltrials:NCT00633932
condition browse [clinicaltrials_vocabulary:condition-browse]
Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [clinicaltrials:NCT00002041]A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis [clinicaltrials:NCT00005921]Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer [clinicaltrials:NCT00081315]clinicaltrials:NCT00123630Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis [clinicaltrials:NCT00123656]clinicaltrials:NCT0013377024 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis [clinicaltrials:NCT00154570]Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus [clinicaltrials:NCT00155805]Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis [clinicaltrials:NCT00175045]Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis [clinicaltrials:NCT00195208]NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis [clinicaltrials:NCT00206180]A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. [clinicaltrials:NCT00206245]A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. [clinicaltrials:NCT00206284]The Effect of Nexium on Transmucosal Esophageal Leak [clinicaltrials:NCT00216788]Esomeprazole for Treatment of GERD in Pediatric Patients [clinicaltrials:NCT00228527]clinicaltrials:NCT00229424clinicaltrials:NCT00251693clinicaltrials:NCT00251719clinicaltrials:NCT00255151clinicaltrials:NCT00255164Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia [clinicaltrials:NCT00256529]Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome [clinicaltrials:NCT00266565]A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders [clinicaltrials:NCT00266578]Data Bank for Eosinophilic Disorders [clinicaltrials:NCT00267475]Budesonide for Eosinophilic Esophagitis [clinicaltrials:NCT00271349]Study to Identify Non-Invasive Markers of Gastrointestinal Allergy [clinicaltrials:NCT00272818]An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients [clinicaltrials:NCT00274703]clinicaltrials:NCT00275561Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis [clinicaltrials:NCT00282555]clinicaltrials:NCT00284908clinicaltrials:NCT00321737Intravenous Mepolizumab In Children With Eosinophilic Esophagitis [clinicaltrials:NCT00358449]clinicaltrials:NCT00426283clinicaltrials:NCT00471094Trial of Montelukast in Eosinophilic Esophagitis [clinicaltrials:NCT00511316]Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis [clinicaltrials:NCT00523354]Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years [clinicaltrials:NCT00538434]Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule [clinicaltrials:NCT00579410]Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis [clinicaltrials:NCT00586963]clinicaltrials:NCT00633932
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Esophagitis [clinicaltrials_resource:43a6013a987f1405a4b7c73ec4918ffa]
Bio2RDF identifier
43a6013a987f1405a4b7c73ec4918ffa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:43a6013a987f1405a4b7c73ec4918ffa
identifier
clinicaltrials_resource:43a6013a987f1405a4b7c73ec4918ffa
title
Esophagitis
@en
type
label
Esophagitis [clinicaltrials_resource:43a6013a987f1405a4b7c73ec4918ffa]
@en
Esophagitis